Latest AI and machine learning research in chemotherapy for healthcare professionals.
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, heterogeneous, and systemic disease defined by a suite of symptoms, including unexplained persistent fatigue, post-exertional malaise (PEM), cognitive impairment, myalgia, orthostatic intolerance, and unrefreshing sleep. The disease mechanism of ME/CFS is unknown, with no effective curative treatments. In this study, we pres...
Dengue, chikungunya, and Zika are diseases of major human concern. Differential diagnosis is complicated in children and adolescents by their overlapping clinical features (signs, symptoms, and complete blood count results). Few studies have directly compared the three diseases. We aimed to identify distinguishing pediatric characteristics of each disease. Data were derived from laboratory-confirm...
Muscle-invasive bladder cancer (MIBC) is associated with poor predictability of response to cisplatin-based neoadjuvant chemotherapy (NAC). Consequent...
Clinical practice guidelines recommend cardiovascular toxicity risk restratification including evaluation of new cardiovascular risk factors and cardi...
Targeted estimation offers a robust and unbiased approach for causal inference of the average treatment effect (ATE) from observational data, even wit...
Progressive supranuclear palsy (PSP) is a neurodegenerative 4R tauopathy clinically presenting with atypical parkinsonism or cognitive behavioral chan...
Deep learning models applied to digital histology can predict gene expression signatures (GES) and offer a low-cost, rapidly available alternative to ...
This study evaluated the prognostic performance of RlapsRisk BC, a multimodal deep learning tool designed to predict distant recurrence-free interval ...
Information from electronic health records (EHRs) may be incorporated into computable phenotype algorithms in efforts to overcome inaccuracies of algo...
Neoadjuvant therapy, involving treatment administered before surgery to shrink tumors, significantly impacts breast cancer management. However, curren...
Clinicopathologic calculators for bladder cancer moderately predict survival and fail to depict the underlying molecular phenotype. We applied urinary...
Neoadjuvant therapy (NAT) is an established treatment for certain high-risk, locally advanced, or unresectable breast cancers, often facilitating brea...
Cancer therapeutic response patterns may be fundamentally influenced by embryonic germ layer origin. Emerging evidence suggests mesoderm-derived malig...
Up to 80% of women breast cancer survivors (BCS), particularly those treated with chemotherapy, report persistent cognitive impairment. Several meta-a...
Response assessment of primary kidney tumors in the consolidation cytoreductive and neoadjuvant settings offers a unique opportunity to inform postope...
Homologous recombination deficiency (HRD) confers sensitivity to poly (ADP-ribose) polymerase (PARP) inhibitors and platinum-based chemotherapy, repre...
Neoadjuvant chemotherapy (NAC) is the standard of care for locally advanced breast cancer. However, the disconnect between efficacy in randomized tria...
The increasing availability of electronic health records (EHRs) provides opportunities to apply machine learning (ML) methods in support of clinical d...
Colon Cancer (CC) is among the most frequently diagnosed malignancies and a leading cause of cancer-related death worldwide. Five-year survival varies...
Colorectal cancer (CRC) exhibits marked heterogeneity across age, ancestry, and treatment context, underscored by the rising incidence of early-onset ...